RegPak Launches Herbal Medicine For Cancer Treatment
Netherlands company, RegPak Bio-Pharma today announced its collaboration with Taiwan based firm Meriyana International Biotechnology to sell Chinese herbal medicine for cancer treatment in India, through its Indian subsidiary CanCure.
Announcing this, Parminder Kaur, CEO of RegPak BioPharma said, “Doctors have been shortlisted to undergo training in Taiwan to work in the CanCure Clinics to be set up in Chandigarh and later, various parts of Punjab.”
She said a substantial number of patients suffer from cancer in various areas of Punjab and claimed that the Chinese medicine would be helpful in treating those patients effectively.
Accompanied by the representatives of Meriyana International, Parminder Kaur said the herbal medicine, ‘Chinmanna’, has undergone several clinical trials in Taiwan, and that RegPak would be introducing it very soon in Europe where it has got the approvals to be introduced as compassionate medicine for terminal cancer patients.
Chinmanna is launched for treatment of various types of cancers including breast, stomach, throat, mouth, pancreas, intestinal and spleen cancer, she said.
- HPV Vaccine 'Protects Males from Cancers' - Global ReportMedical Devices & Pharma
- Hologic: How Can Technology be Harnessed to Combat Cancer?Technology & AI
- Asian cancer survivors break stigma in their communitiesSustainability
- Novartis breast cancer drug trial achieves positive resultsMedical Devices & Pharma